The AUC and the 95 % CI were calculated for adiponectin after adjustment for sex, age, and further adjustment for insulin, BMI or waist circumference, in order to assess the ability of adiponectin to discriminate between participants with MetS and participants without MetS. The gene discussed is INS; the disease is metabolic syndrome.